The In vivo expression of mutations constructed within helix 34 of 16S rRNA has been examined together with a nonsense tRNA suppressor for their action at stop codons. The data revealed two novel results: in contrast to previous findings, some of the rRNA mutations affected suppression at UAA and UAG nonsense codons. Secondly, both an increase and a decrease in the efficiency of the suppressor tRNA were Induced by the mutations. This is the first report that rRNA mutations decreased the efficiency of a suppressor tRNA. The data are interpreted as there being competition between the two release factors (RF-1 and RF-2) for an overlapping domain and that helix 34 influences this interaction.
INTRODUCTION
The events at translation termination remain elusive, although there is an accumulating body of evidence suggesting that, in addition to the protein factors (release factors: RF-1, -2 and -3), 16S ribosomal RNA participates in this reaction [1] [2] [3] . Ribosomes carrying the mutation in which base C1054 in helix 34 of 16S rRNA is deleted, enhanced the efficiency of suppressor tRNA molecules acting at the three stop codons (UAG, UAA and UGA) [4] . Since this observation was not consistent with the model of base-pairing between the mRNA stop codon and the 16S rRNA [3] , our attention was directed towards the possible interaction between this helix and the release factors.
A series of mutations within helix 34 is now available (reviewed in [5] ), including the base substitutions at nucleotide position 1192 that confer resistance to spectinomycin [6] (Figure 1 ). We have further characterised these mutations in vivo for their ability to enhance the activities of a suppressor tRNA molecule acting at UAA and UAG stop codons. The results presented here together with those previously described for the effect of the mutated ribosomes on the suppression of UGA stop codons [1] [2] [3] revealed two striking trends: mutations which did affect the UG-A-dependent termination event enhanced the suppression activity of the tRNA, whereas mutations which affected the UA-G-dependent termination event caused the ribosomes to reduce the suppressor tRNA activity. These results together have led us to propose that both release factors (RF-1 and RF-2) initially compete with one another for a partially overlapping binding domain on the 30S subunit. This is consistent with the fact that both release factors are able to interact at the UAA nonsense codon (RF-1 recognises UAA and UAG whereas RF-2 recognises UAA and UGA). We believe that alterations within helix 34 reduced the competitive ability of RF-2, and as a consequence, indirectly increased the efficiency of the RF-1 dependent termination event. This model further implies that the release factors initially interact with the ribosome in a nonsense codonindependent manner.
MATERIALS AND METHODS

Strains and Plasmids
Construction and preliminary characterisation of the mutations in helix 34 have all been previously described (reviewed in [5] ; [6] ) and were a generous gift from Dr. H.U. Goringer. The mutations were expressed as derivatives of either plasmid pKK3535 (1192A, 1192G, 1192U, 1199C and 1202C) which contains the complete rrnB operon including the natural promoters P,P 2 [7] , or from plasmid pNO2680 (1054A, 1054G and 1054U) which contains the rrnB transcription unit under the control of the lambda P L promoter [8] . It has previously been shown that the mutated ribosomes represent between 40% and 65% of the 70S population [5] .
Stop codon suppression analysis was achieved in vivo using the system in which ribosomes must translate through a termination codon in order to synthesize functional j3-galactosidase [9] . The test strains available were: DEVl-focZUA-G, DEV14-/acZUAA and DEV15-ZacZUGA. Derivatives of these strains carrying chromosomally encoded suppressor tRNAs have been previously described [4] .
The suppressor tRNA, Su7-UAA, is a derivative of tRNA Tr P that contains an altered anticodon loop [10] and was a gift from Dr. M. Yarus. Plasmid pSWC 115 contains the suppressor tRNA under lac promoter control [10] . For our purposes the tRNA was subcloned from pSWCl 15 on the 2.8kb Hindm-Hpal restriction fragment and ligated directly into the HindTJI and Smal restriction endonuclease sites on M13mpl9, purchased from New England Biolabs, Inc. Functional expression of the M13mpl9 borne suppressor tRNA (M13suptRNA) was confirmed by transfection into DEV14-/acZUAA and the subsequent generation of blue plaques on 2YT plates supplemented with 5-bromo-4-chloro-3-indolyl-/3-D-galactosidase (2% in dimethyl formamide) and lmM Isopropyl-/3-D-galactopyranoside (IPTG) [11] .
Preparation of cell extracts and enzyme assays Transformants of either the pKK3535 or pNO2680 plasmids and their derivatives were grown at 37 °C with gentle agitation in 2YT medium supplemented with IPTG (lmM) and ampicillin (200/ig/ml) until early logarithmic growth and then infected with M13suptRNA at a multiplicity of infection equal to 10. lml samples were withdrawn 3 hours after the initial infection, and rapidly cooled on ice. Cell extracts were prepared as described elsewhere [12] with the following modifications. The cells were harvested by centrifugation for 5 min. in a Heraeus Biofuge (maximum speed) and washed in 500/il lysis buffer (20mM Tris.Cl pH 7.8, lOmM EDTA) before being resuspended in 200/d lysis buffer containing lysozyme (2/tg/ml). The cells were disrupted by the method of repeated freeze-thaw lysis. The cleared cell extracts were recovered following centrifugation at 12,000 revs/min for 10 min. The /3-galactosidase and /3-lactamase activities were determined 2 to 3 times for each sample.
The levels of /3-galactosidase were measured essentially according to [13] , in a final volume of lml Z-buffer at 28°C, the reaction being started by the addition of 200/J o-nitro-phenyl-/3-D-galactopyranoside (4mg/ml). The reaction was terminated by the addition of 500/tl 1M Na 2 CO 3 . The activity was measured as /3-gal units = [10 3 
The levels of /3-lactamase activity encoded by the plasmid borne gene present on both plasmids pKK3535 and pNO2680 were measured essentially according to [14] in 1.0ml lOOmM phosphate buffer containing cephaloridine (41.5/ig/ml). One unit of/3-lactamase activity equals 1 /imol of cephaloridine hydrolyzed at 37°C in 1 ml per min. per
RESULTS
Transformation of Suppressor strains
A series of mutations constructed within helix 34 of the 16S rRNA have been examined previously for their affect on nonsense codon suppression (reviewed in [5] ). These mutations, together with those at nucleotide position 1192 [6] , were analyzed here for their effect in combination with a suppressor tRNA on the viability of their host. The mutations were expressed from derivatives of either plasmid pKK3535 (1192A, 1192G, U92U, 1199C and 1202C) or pNO2680 (1054A, 1054G and 1054U) following their transformation of the test strains: DEVl-/acZUAG and DEV14-/acZUAA and their derivatives carrying the chromosomal ly encoded suppressor tRNAs [4] .
Transformants could be readily obtained in the DEV-lacZ strains that lacked the suppressor tRNAs. However, only those transformants containing the 1202C mutation could be obtained in the DEV-lacZ strains that contained the chromosomally encoded suppressor tRNAs. Expression of the mutations located at nucleotide positions 1192, 1199 and 1054 was lethal to the host when in combination with the suppressor tRNAs.
Expression of mutations in helix 34 caused both an increase and a decrease in suppressor tRNA activities The mutated nbosomes were further characterised for their effect on the efficiency of a suppressor tRNA to interact at the UAA and UAG nonsense codons. Since the presence of a suppressor tRNA was lethal in combination with the expression of these mutations, we had to design a system in which the mutated ribosomes were initially expressed in the absence of the "V. suppressor tRNA. The suppressor tRNA was then subsequently introduced into the host and, at a specific time point, the suppression activity at the nonsense codons measured. This was achieved by cloning the derivative of tRNA Tr P, Su7-UAA, which contains a mutation in the anticodon loop [10] , into the bacteriophage M13mpl9 (designated M13suptRNA) (materials and methods) and using this construct to introduce the suppressor tRNA into the transformants that contained the mutated ribosomes. The Su7-UAA tRNA is a weak suppressor of both UAA and UAG nonsense codons, and most probably inserts glutamine [10] .
The efficiency of the suppressor tRNA to compete with the release factors at the in frame nonsense codon located within the lacZ structural gene of the DEV-lacZ transformants was measured in terms of the amount of /3-galactosidase activity synthesized [9] . This activity was normalised to the level of /3-lactamase activity synthesized in the host at precisely the same point in time. The |3-lactamase gene contains no internal in frame stop codon. Therefore, the amount of this enzyme synthesised is a reflection of the overall in vivo translation activity. The ratio of /3-galactosidase activity relative to that of /3-lactamase represents the level of suppression relative to translation activity. The values obtained in the presence of the plasmids expressing the mutated 16S rRNAs were compared to those obtained in the presence of the plasmids encoding the wild type 16S rRNA (pKK3535 and pNO2680), whose values were set to one. These results represent the relative levels of suppression.
Transformants of the DEVl-focZUAG and DEV14-tocZUAA strains containing either plasmid pKK3535 or pNO2680 or their derivatives encoding the mutations at nucleotide positions 1192 (A, G and U), 1199 (C), 1202 (C) and 1054 (A, G and U) were grown at 37°C until early logarithmic growth and then infected with M13suptRNA, at a multiplicity of infection equal to 10. Samples were withdrawn three hours after infection and the levels The ratio of j9-galactosidase activity (Gal) relative to |3-lactamase activity (Lac) obtained in the presence of the wild type control plasmids (pKK3535 and pNO2680) is set to one in each case (Rel. Activ.*). The ratios obtained in the presence of the mutated nbosomes are normalised to the wild type values and together represent the relative values of suppression activity (Rel. Activ*.). The 0-galactosidase (Gal) and /S-lactamase (Lac) units are defined elsewhere (materials and methods [13; 14] ). The /3-galactosidase and 0-lactamase activities were determined 2 to 3 times for each sample and reflect the average of at least three independent experiments The standard deviations (SD) for each set of experiments are presented.
of/3-galactosidase and /3-lactamase activities were measured. The data are presented in Table I . In the absence of the suppressor tRNA, no /3-galactosidase activity was detected, as has been previously demonstrated [4] , The relative levels of suppression at the UAG nonsense codon in the DEVl-tacZUAG strain were apparently unaffected by the presence of the mutations 1054A, 1054U, 1192U and 1199C (Table I ) . The 1054G, 1192A, 1192G and 1202C mutations caused the efficiency of the suppressor tRNA to be decreased. The relative levels of suppression at UAA nonsense codons in DEV 14-lacZUAA varied considerably, dependent upon the 16S rRNA mutation. These levels increased in the presence of the mutations 1054A, 1054G, 1192G and 1199C and by direct contrast, decreased in the presence of the 1202C mutation. The mutations 1054U, 1192A and 1192U gave values that were the same as wild type.
DISCUSSION
Evidence is presented here which shows that the in vivo expression of mutations constructed within helix 34 of 16S rRNA (figure 1), affected the efficiency of a nonsense suppressor tRNA. These data revealed two novel findings: firstly, a number of these rRNA mutations altered the suppression events at UAA and UA-G nonsense codons. This was in contrast to the previous conclusion that the mutations specifically affected suppression at the UGA nonsense codon in the lacZ gene encoded in the test strain DEV15-focZUGA [2;3] . Secondly, these mutations effected both an increase and a decrease in the efficiency of the suppressor tRNA. This is the first report that mutations in the 16S rRNA decreased the efficiency of a suppressor tRNA.
The magnitude of the effect of these rRNA mutations on the suppressor tRNA was dependent upon the nonsense codon and the position and nature of the mutation within the helix. However, two trends were evident: mutations that affected the UAGdependent suppression event did so by decreasing the efficiency of the suppressor tRNA, whereas mutations that affected the UGAdependent suppression event, enhanced the efficiency of the suppressor tRNA (Table II [ 2;3] ). The decrease in suppression levels in the presence of the mutations 1054G and 1202C, were in the range of 50% to 60%. If this decrease is attributed to the affect of the mutated ribosomes, which represent between approximately 42% (1054G) and 65% (1202Q of the total 70S population [5] , these then represented the maximal decrease that we could in fact measure. In other words, the altered ribosomes appeared to severely reduce the activity of the suppressor tRNA. By direct contrast, mutations 1054G, 1199C and 1202C all enhanced the activity of the tRNA acting at the UGA nonsense codon [2;3] . Clearly, the same mutation (for example 1054G and 1202Q exhibited opposing affects on the suppressor tRNA dependent upon the nonsense codon. This became even more evident when events at the UAA nonsense codon were analyzed: mutations 1054A, 1054G, 1192G and 1199C increased the suppression levels and the 1202C mutation decreased the suppression event. How could the same mutation be seen to both enhance and decrease the efficiency of a suppressor tRNA (Table II) ?
The suppression event represents a competition between the release factor and the suppressor tRNA for the nonsense codon. An increase in suppression activity indicates that the suppressor tRNA competes more successfully than the release factor for the nonsense codon. The simplest interpretation for this would be a reduced binding affinity of the release factor for its binding site on the ribosome. By direct contrast, a decrease in suppression activity indicates that it is the release factor that competes with greater efficiency than the suppressor tRNA. Therefore, when the data were interpreted in terms of the specific release factor involved, a clearer picture emerged.
Mutations that affected the RF-1 specific UAG-dependent event (1054G, 1192A, 1192G and 1202C), decreased the efficiency of the suppressor tRNA. Mutations that affected the RF-2 specific UGA-dependent event (1054G, 1199C and 1202C), all increased the efficiency of the suppression event, probably by decreasing the binding affinity for RF-2. The question could now be rephrased as to how the same mutation could increase the binding affinity for one release factor and yet decrease that of the other?
Our interpretation is that the factors compete for a partially overlapping binding site that is at least influenced by helix 34. Alterations within this binding domain evidently decreased in vivo the binding affinity for RF-2. This could not be detected in the in vitro assay which is currently used to analyse nonsense codondependent binding of the release factor to the ribosome (reviewed in [5] ). A decreased affinity of this factor (RF-2) for its binding site would reduce the competition for the overlapping domain and thus effectively increase the binding affinity for RF-1. Therefore, mutations 1054G and 1192G were interpreted as decreasing the binding affinity of RF-2 and as a consequence, indirectly increasing the efficiency of the RF-1 directed UA-G-dependent termination event.
The results of suppression at the UAA-dependent termination event were not as clear cut. Evidently the mutations have more subtle affects on the interaction of the release factors than by for example, simply abolishing binding by RF-2. Since recognition of the UAA nonsense codon does not involve a third factor, the mutations would appear to affect to differing extents, the affinities of RF-1 and RF-2 for the ribosome. The pattern of events in the presence of the 1202C mutation were readily explained: a decrease in the activity of RF-2 would result in an increased efficiency of RF-1 acting at both UAG and UAA nonsense codons. However, the 1199C mutation had a greater affect on RF-2 than RF-1 as was demonstrated by the increased suppression activity at UAA and UGA nonsense codons in contrast to the RF-1, UAG-dependent event.
These data provided an explanation for why transformants containing the chromosomally encoded suppressor tRNAs could only be obtained in the presence of the 1202C mutation and not the other helix 34 mutations. Only this mutation effected a decrease in the activity of the suppressor tRNA at both the UAA and UAG nonsense codons. The UAA stop codon is the most commonly utilized in E. coli, including both the low and highly expressed genes [15] . Therefore, suppression at UAA nonsense codons would increase the synthesis of readthrough products causing lethality, which must have occurred in the presence of a number of the other helix 34 mutations (1054A, 1054G, 1192G and 1199C). This was also consistent with the observation that only weak suppressors for UAA can be isolated [10] .
Competition between the release factors for an overlapping binding site further implies that the initial binding of the release factors to the ribosome is independent of the nonsense codon. If this were indeed the case then over expression of the release factor might, even at sense codons, compete widi elongation factor-Tu for their common binding domain on the 70S ribosome. However, subsequent recognition by the release factor for the specific stop codon would presumably then precede completion of the termination event. Such competition may provide an explanation for the lethality attributed to over expression of the release factor. This model is in good agreement with Tate and coworkers who proposed that initial binding by the release factors precedes a direct interaction with the nonsense codon [16] . Immunoelectron microsocpy studies reveal two domains of interaction by the release factors on the 30S subunit [17] . Furthermore, that the factors occupy distinct but overlapping binding sites is supported by the fact that both release factors recognise the UAA nonsense codon and that immunoelectron microscopy studies position RF-1 somewhat lower than RF-2 on the small subunit [18] . Ribosomes containing the C1054-deletion mutation increased the efficiency of suppressors acting at all three nonsense codons [4] , thus indicating that the mutation affected the functional interaction by both release factors.
We are at this time unable to draw conclusions other than that the mutations probably influence the binding affinities of the release factors to differrent extents. Furthermore, the nucleotide sequence of this helix indicates that it is flexible and can be represented in a number of alternative secondary structure configurations [5; 19] : this adds further to our problem of the interpretation of the precise affects of the mutations on the structure of the helix. Interestingly, this helix has two, repetitious, four base sequence motifs: 5'-UGNC-3' and 5'-GUCA-3', where 'N' represents either A, C, G or U (figure 2). The UGNC motif is also found encompassing nucleotide positions C726 and G517 in 16S rRNA, mutations at which also affect the suppression event [20;21] (unpublished observations). The tertiary structural arrangement of the UGNC motifs indicates that they are aligned on the same side of helix 34 [5] . The significance, if any, of these motifs remains unknown, but they do provide an intriguing basis for further speculation.
